Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,440 | 4,029 | 5,319 | 6,568 | 6,531 |
| Other current assets | 12 | 12 | 0 | 0 | 12 |
| TOTAL | $7,561 | $4,260 | $5,648 | $7,007 | $6,626 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 70 | 103 | 12 | 12 | 0 |
| TOTAL | $70 | $103 | $12 | $12 | $N/A |
| Total Assets | $7,631 | $4,363 | $5,660 | $7,018 | $6,626 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 408 | 492 | 476 | 626 | 441 |
| Accrued Expenses | 808 | 692 | 1,158 | 985 | 825 |
| TOTAL | $1,285 | $1,287 | $1,635 | $1,611 | $1,266 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,285 | $1,287 | $1,635 | $1,611 | $1,266 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 167 | 161 | 121 | 121 | 117 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -82,684 | -80,570 | -78,605 | -76,844 | -75,325 |
| TOTAL | $6,346 | $3,075 | $4,025 | $5,408 | $5,360 |
| Total Liabilities And Equity | $7,631 | $4,363 | $5,660 | $7,018 | $6,626 |